{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T06:52:55Z","timestamp":1764053575434,"version":"build-2065373602"},"reference-count":80,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.bmc.2019.01.033","type":"journal-article","created":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T04:35:07Z","timestamp":1548822907000},"page":"865-879","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Synthesis and biological evaluation of new long-chain squaramides as anti-chagasic agents in the BALB\/c mouse model"],"prefix":"10.1016","volume":"27","author":[{"given":"Rub\u00e9n","family":"Mart\u00edn-Escolano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clotilde","family":"Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Vega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1lvaro","family":"Martin-Montes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Encarnaci\u00f3n","family":"Medina-Carmona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2478-3807","authenticated-orcid":false,"given":"Carmen","family":"Rotger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"S\u00e1nchez-Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2019.01.033_b0005","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1590\/S0074-02762009000900005","article-title":"Current epidemiological trends of Chagas disease in Latin America and future challenges in epidemiology, surveillance, and health policy","volume":"104","author":"Moncayo","year":"2009","journal-title":"Mem Inst Oswaldo Cruz."},{"key":"10.1016\/j.bmc.2019.01.033_b0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001861","article-title":"Is Chagas disease really the \u201cnew HIV\/AIDS of the Americas\u201d?","volume":"6","author":"Tarleton","year":"2012","journal-title":"PLoS Negl Trop Dis."},{"key":"10.1016\/j.bmc.2019.01.033_b0015","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1128\/CMR.00005-11","article-title":"Trypanosoma cruzi and chagas\u2019 disease in the United States","volume":"24","author":"Bern","year":"2011","journal-title":"Clin Microbiol Rev."},{"key":"10.1016\/j.bmc.2019.01.033_b0020","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.actatropica.2009.07.019","article-title":"Chagas disease in Spain, the United States and other non-endemic countries","volume":"115","author":"Gascon","year":"2010","journal-title":"Acta Trop."},{"key":"10.1016\/j.bmc.2019.01.033_b0025","doi-asserted-by":"crossref","first-page":"814","DOI":"10.4269\/ajtmh.13-0726","article-title":"Neglected parasitic infections in the United States: Chagas Disease","volume":"90","author":"Montgomery","year":"2014","journal-title":"Am J Trop Med Hyg."},{"key":"10.1016\/j.bmc.2019.01.033_b0030","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2471\/BLT.13.134072","article-title":"Economic crisis and increased immigrant mobility: new challenges in managing Chagas disease in Europe","volume":"92","author":"Jackson","year":"2014","journal-title":"Bull World Health Organ."},{"key":"10.1016\/j.bmc.2019.01.033_b0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003540","article-title":"Prevalence of Chagas disease in Latin-American migrants living in Europe: a systematic review and meta-analysis","volume":"9","author":"Requena-M\u00e9ndez","year":"2015","journal-title":"PLoS Negl Trop Dis."},{"key":"10.1016\/j.bmc.2019.01.033_b0040","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11908-012-0259-3","article-title":"Chagas disease in non-endemic countries: epidemiology, clinical presentation and treatment","volume":"14","author":"P\u00e9rez-Molina","year":"2012","journal-title":"Curr Infect Dis Rep."},{"key":"10.1016\/j.bmc.2019.01.033_b0045","unstructured":"DNDi - Drugs for Neglected Diseases initiative. Diseases & Projects - Chagas Disease. https:\/\/www.dndi.org\/diseases-projects\/chagas\/. Accessed 5 October 2018."},{"key":"10.1016\/j.bmc.2019.01.033_b0050","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1073\/pnas.0711014105","article-title":"A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes","volume":"105","author":"Wilkinson","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmc.2019.01.033_b0055","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1590\/S0074-02762009000900042","article-title":"The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease","volume":"104","author":"Marin-Neto","year":"2009","journal-title":"Mem Inst Oswaldo Cruz."},{"key":"10.1016\/j.bmc.2019.01.033_b0060","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.actatropica.2009.10.023","article-title":"Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches","volume":"115","author":"Urbina","year":"2010","journal-title":"Acta Trop."},{"key":"10.1016\/j.bmc.2019.01.033_b0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1590\/S0074-02762002000100001","article-title":"A critical review on Chagas disease chemotherapy","volume":"97","author":"Rodrigues Coura","year":"2002","journal-title":"Mem Inst Oswaldo Cruz."},{"key":"10.1016\/j.bmc.2019.01.033_b0070","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1586\/14787210.7.2.157","article-title":"Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities","volume":"7","author":"Viotti","year":"2009","journal-title":"Expert Rev Anti Infect Ther."},{"key":"10.1016\/j.bmc.2019.01.033_b0075","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S0140-6736(96)04128-1","article-title":"Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection","volume":"348","author":"de Andrade","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.bmc.2019.01.033_b0080","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S1473-3099(01)00065-2","article-title":"Clinical and epidemiological aspects of Chagas disease","volume":"1","author":"Prata","year":"2001","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.bmc.2019.01.033_b0085","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1093\/jac\/dkx516","article-title":"What to expect and when: Benznidazole toxicity in chronic Chagas\u2019 disease treatment","volume":"73","author":"Aldasoro","year":"2018","journal-title":"J Antimicrob Chemother."},{"key":"10.1016\/j.bmc.2019.01.033_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actatropica.2015.12.017","article-title":"Current drug therapy and pharmaceutical challenges for Chagas disease","volume":"156","author":"Bermudez","year":"2015","journal-title":"Acta Trop."},{"key":"10.1016\/j.bmc.2019.01.033_b0095","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/infdis\/jis331","article-title":"Benznidazole-resistance in Trypanosoma cruzi is a readily acquired trait that can arise independently in a single population","volume":"206","author":"Mejia","year":"2012","journal-title":"J Infect Dis."},{"key":"10.1016\/j.bmc.2019.01.033_b0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000300","article-title":"The egnlected tropical diseases of Latin America and the Caribbean: a review of disease burden and distribution and a roadmap for control and elimination","volume":"2","author":"Hotez","year":"2008","journal-title":"PLoS Negl Trop Dis."},{"key":"10.1016\/j.bmc.2019.01.033_b0105","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrd3480","article-title":"How were new medicines discovered?","volume":"10","author":"Swinney","year":"2011","journal-title":"Nat Rev Drug Discov."},{"key":"10.1016\/j.bmc.2019.01.033_b0110","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.drudis.2013.11.005","article-title":"Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines","volume":"19","author":"Jin","year":"2014","journal-title":"Drug Discov Today."},{"key":"10.1016\/j.bmc.2019.01.033_b0115","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.exppara.2011.02.025","article-title":"Aryl piperazine and pyrrolidine as antimalarial agents. Synthesis and investigation of structure-activity relationships","volume":"128","author":"Mendoza","year":"2011","journal-title":"Exp Parasitol."},{"key":"10.1016\/j.bmc.2019.01.033_b0120","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1039\/c004165c","article-title":"Rationally designed squaryldiamides - a novel class of sugar-nucleotide mimics?","volume":"8","author":"Niewiadomski","year":"2010","journal-title":"Org Biomol Chem."},{"key":"10.1016\/j.bmc.2019.01.033_b0125","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1039\/c2md20011b","article-title":"Squaric acid: a valuable scaffold for developing antimalarials?","volume":"3","author":"Kumar","year":"2012","journal-title":"Medchemcomm."},{"key":"10.1016\/j.bmc.2019.01.033_b0130","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/j.bmc.2016.03.005","article-title":"Novel squaramides with in vitro liver stage antiplasmodial activity","volume":"24","author":"Ribeiro","year":"2016","journal-title":"Bioorganic Med Chem."},{"key":"10.1016\/j.bmc.2019.01.033_b0135","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1021\/jm4017015","article-title":"Synthesis and biological evaluation of N, N\u2032-squaramides with high in vivo efficacy and low toxicity: toward a low-cost drug against Chagas disease","volume":"57","author":"Olmo","year":"2014","journal-title":"J Med Chem."},{"key":"10.1016\/j.bmc.2019.01.033_b0140","doi-asserted-by":"crossref","first-page":"9438","DOI":"10.1039\/C6CC04089F","article-title":"Phosphate bioisostere containing amphiphiles: a novel class of squaramide-based lipids","volume":"52","author":"Saha","year":"2016","journal-title":"Chem Commun."},{"key":"10.1016\/j.bmc.2019.01.033_b0145","doi-asserted-by":"crossref","first-page":"12715","DOI":"10.1021\/ja027131f","article-title":"SquarylgGroup as a new mimic of phosphate group in modified oligodeoxynucleotides: synthesis and properties of new oligodeoxynucleotide analogues containing an internucleotidic squaryldiamide linkage","volume":"124","author":"Sato","year":"2002","journal-title":"J Am Chem Soc."},{"key":"10.1016\/j.bmc.2019.01.033_b0150","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1021\/acs.joc.6b02963","article-title":"Kinetic analysis and mechanism of the hydrolytic degradation of squaramides and squaramic acids","volume":"82","author":"Ximenis","year":"2017","journal-title":"J Org Chem."},{"key":"10.1016\/j.bmc.2019.01.033_b0155","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/cber.19911240539","article-title":"Anticancer Agents, 15. Squaric acid diethyl ester: a new coupling reagent for the formation of drug biopolymer conjugates. Synthesis of squaric acid ester amides and diamides","volume":"124","author":"Tietze","year":"1991","journal-title":"Chem Ber."},{"key":"10.1016\/j.bmc.2019.01.033_b0160","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1021\/jo035546t","article-title":"Conformational preferences and self-template macrocyclization of squaramide-based foldable modules","volume":"69","author":"Rotger","year":"2004","journal-title":"J Org Chem."},{"key":"10.1016\/j.bmc.2019.01.033_b0165","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.actatropica.2008.08.006","article-title":"Biological characterization of Trypanosoma cruzi stocks from domestic and sylvatic vectors in Sierra Nevada of Santa Marta, Colombia","volume":"108","author":"T\u00e9llez-Meneses","year":"2008","journal-title":"Acta Trop."},{"key":"10.1016\/j.bmc.2019.01.033_b0170","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1002\/j.1460-2075.1990.tb07462.x","article-title":"Trypanosoma cruzi glycosomal glyceraldehyde-3-phosphate dehydrogenase does not conform to the \u201chotspot\u201d topogenic signal model","volume":"9","author":"Kendall","year":"1990","journal-title":"EMBO J."},{"key":"10.1016\/j.bmc.2019.01.033_b0175","doi-asserted-by":"crossref","first-page":"5643","DOI":"10.1021\/acs.jmedchem.8b00468","article-title":"Second generation of Mannich base type derivatives with in vivo activity against Trypanosoma cruzi","volume":"61","author":"Mart\u00edn-Escolano","year":"2018","journal-title":"J Med Chem."},{"key":"10.1016\/j.bmc.2019.01.033_b0180","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1472-6750-12-73","article-title":"Aggravation of cold-induced injury in Vero-B4 cells by RPMI 1640 medium - identification of the responsible medium components","volume":"12","author":"Pless-Petig","year":"2012","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.bmc.2019.01.033_b0185","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0166-6851(85)90073-8","article-title":"In vitro differentiation of Trypanosoma cruzi under chemically defined conditions","volume":"16","author":"Contreras","year":"1985","journal-title":"Mol Biochem Parasitol."},{"key":"10.1016\/j.bmc.2019.01.033_b0190","doi-asserted-by":"crossref","first-page":"35351","DOI":"10.1038\/srep35351","article-title":"Nitroheterocyclic drugs cure experimental Trypanosoma cruzi infections more effectively in the chronic stage than in the acute stage","volume":"6","author":"Francisco","year":"2016","journal-title":"Sci Rep."},{"key":"10.1016\/j.bmc.2019.01.033_b0195","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1084\/jem.20071393","article-title":"Divergent roles of endothelial NF-\u03baB in multiple organ injury and bacterial clearance in mouse models of sepsis","volume":"205","author":"Ye","year":"2008","journal-title":"J Exp Med."},{"key":"10.1016\/j.bmc.2019.01.033_b0200","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejmech.2015.10.034","article-title":"Synthesis and evaluation of in vitro and in vivo trypanocidal properties of a new imidazole-containing nitrophthalazine derivative","volume":"106","author":"Olmo","year":"2015","journal-title":"Eur J Med Chem."},{"key":"10.1016\/j.bmc.2019.01.033_b0205","doi-asserted-by":"crossref","unstructured":"Bahia MT, de Andrade IM, Martins TA, do Nascimento \u00c1F, Diniz Lde F, Caldas IS, Talvani A, Trunz BB, Torreele E, Ribeiro I. Fexinidazole: a potential new drug candidate for Chagas disease. PLoS Negl Trop Dis. 2012;6:e1870. https:\/\/doi.org\/10.1371\/journal.pntd.0001870.","DOI":"10.1371\/journal.pntd.0001870"},{"key":"10.1016\/j.bmc.2019.01.033_b0210","first-page":"523","volume":"44","author":"Fern\u00e1ndez-Becerra","year":"1997","journal-title":"Comparative aspects of energy metabolism in plant trypanosomatids"},{"key":"10.1016\/j.bmc.2019.01.033_b0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093936","article-title":"Trypanosoma cruzi cell death induced by the Morita-Baylis-Hillman adduct 3-Hydroxy-2-methylene-3-(4-nitrophenylpropanenitrile)","volume":"9","author":"Sandes","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bmc.2019.01.033_b0220","article-title":"Trypanosoma cruzi: Seroprevalence detection in suburban population of Santiago de Quer\u00e9taro (Mexico)","volume":"2012","author":"L\u00f3pez-C\u00e9spedes","year":"2011","journal-title":"Sci World J."},{"key":"10.1016\/j.bmc.2019.01.033_b0225","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem."},{"key":"10.1016\/j.bmc.2019.01.033_b0230","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/0003-2697(87)90489-1","article-title":"Assaying for superoxide dismutase activity: some large consequences of minor changes in conditions","volume":"161","author":"Beyer","year":"1987","journal-title":"Anal Biochem."},{"key":"10.1016\/j.bmc.2019.01.033_b0235","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijantimicag.2004.08.010","article-title":"In vitro activity of C20-diterpenoid alkaloid derivatives in promastigotes and intracellular amastigotes of Leishmania infantum","volume":"25","author":"Gonz\u00e1lez","year":"2005","journal-title":"Int J Antimicrob Agents."},{"key":"10.1016\/j.bmc.2019.01.033_b0240","doi-asserted-by":"crossref","first-page":"12715","DOI":"10.1021\/ja027131f","article-title":"Squaryl group as a new mimic of phosphate group in modified oligodeoxynucleotides: synthesis and properties of new oligodeoxynucleotide analogues containing an internucleotidic squaryldiamide linkage","volume":"124","author":"Sato","year":"2002","journal-title":"J Am Chem Soc."},{"key":"10.1016\/j.bmc.2019.01.033_b0245","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1087057114550585","article-title":"Chagas disease drug discovery: toward a new era","volume":"20","author":"Chatelain","year":"2014","journal-title":"J Biomol Screen."},{"key":"10.1016\/j.bmc.2019.01.033_b0250","first-page":"107","article-title":"Nitroheterocyclic compounds are more efficacious than CYP51inhibitors against Trypanosoma cruzi: implications for Chagas disease drug discovery and development","volume":"109","author":"Moraes","year":"2016","journal-title":"Eur J Med Chem."},{"key":"10.1016\/j.bmc.2019.01.033_b0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001412","article-title":"Integrated dataset of screening hits against multiple neglected disease pathogens","volume":"5","author":"Nwaka","year":"2011","journal-title":"PLoS Negl Trop Dis."},{"key":"10.1016\/j.bmc.2019.01.033_b0260","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1590\/S0036-46652000000200007","article-title":"Evolutive behavior towards cardiomyopathy of treated (nifurtimox or benznidazole) and untreated chronic chagasic patients","volume":"42","author":"Fabbro De Suasn\u00e1bar","year":"2000","journal-title":"Rev Inst Med Trop Sao Paulo."},{"key":"10.1016\/j.bmc.2019.01.033_b0265","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.2174\/092986712802884222","article-title":"Innovative lead compounds and formulation strategies as newer kinetoplastid therapies","volume":"19","author":"Espuelas","year":"2012","journal-title":"Curr Med Chem."},{"key":"10.1016\/j.bmc.2019.01.033_b0270","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.actatropica.2009.10.007","article-title":"Benznidazole alters the pattern of Cyclophosphamide-induced reactivation in experimental Trypanosoma cruzi-dependent lineage infection","volume":"113","author":"Santos","year":"2010","journal-title":"Acta Trop."},{"key":"10.1016\/j.bmc.2019.01.033_b0275","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-3024.1994.tb00325.x","article-title":"Trypanosoma cruzi infection in mice induces a polyisotypic hypergammaglobulinaemia and parasite-specific response involving high lgG2a concentrations and highly avid lgG1 antibodies","volume":"16","author":"El Bouhdidi","year":"1994","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.bmc.2019.01.033_b0280","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.micinf.2010.03.005","article-title":"The innate immune response to Trypanosoma cruzi infection","volume":"12","author":"Kayama","year":"2010","journal-title":"Microbes Infect."},{"key":"10.1016\/j.bmc.2019.01.033_b0285","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1128\/AAC.00520-15","article-title":"Limited ability of Posaconazole to cure both acute and chronic Trypanosoma cruzi infections revealed by highly sensitive in vivo imaging","volume":"59","author":"Francisco","year":"2015","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.bmc.2019.01.033_b0290","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1128\/AAC.05135-11","article-title":"Activation of benznidazole by trypanosomal type I nitroreductases results in glyoxal formation","volume":"56","author":"Hall","year":"2012","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.bmc.2019.01.033_b0295","first-page":"30426","article-title":"Trypanosoma cruzi genetic diversity: Something new for something known about Chagas disease manifestations, serodiagnosis and drug sensitivity","volume":"S0001\u2013706X(17)","author":"Zingales","year":"2017","journal-title":"Acta Trop."},{"key":"10.1016\/j.bmc.2019.01.033_b0300","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1017\/S003118201300142X","article-title":"Screening strategies to identify new chemical diversity for drug development to treat kinetoplastid infections","volume":"141","author":"Don","year":"2014","journal-title":"Parasitology"},{"key":"10.1016\/j.bmc.2019.01.033_b0305","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2174\/1381612023396177","article-title":"Chemotherapy of Chagas Disease","volume":"8","author":"Urbina","year":"2002","journal-title":"Curr Pharm Des."},{"key":"10.1016\/j.bmc.2019.01.033_b0310","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/cmi.12297","article-title":"Bioluminescence imaging of chronic Trypanosoma cruzi infections reveals tissue-specific parasite dynamics and heart disease in the absence of locally persistent infection","volume":"16","author":"Lewis","year":"2014","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.bmc.2019.01.033_b0315","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1007\/s10096-016-2733-6","article-title":"Success of benznidazole chemotherapy in chronic Trypanosoma cruzi-infected patients with a sustained negative PCR result","volume":"35","author":"Murcia","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"10.1016\/j.bmc.2019.01.033_b0320","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1136\/heart.89.10.1186","article-title":"Risk progression to chronic Chagas cardiomyopathy: influence of male sex and of parasitaemia detected by polymerase chain reaction","volume":"89","author":"Basquiera","year":"2003","journal-title":"Heart"},{"key":"10.1016\/j.bmc.2019.01.033_b0325","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.protis.2005.10.001","article-title":"Trypanosomatid biology and euglenozoan evolution: new insights and shifting paradigms revealed through genome sequencing","volume":"156","author":"Ginger","year":"2005","journal-title":"Protist."},{"key":"10.1016\/j.bmc.2019.01.033_b0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molbiopara.2006.03.017","article-title":"Energy metabolism of trypanosomatids: Adaptation to available carbon sources","volume":"149","author":"Bringaud","year":"2006","journal-title":"Mol Biochem Parasitol."},{"key":"10.1016\/j.bmc.2019.01.033_b0335","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1096\/fasebj.6.13.1397837","article-title":"Aerobic fermentation of glucose by trypanosomatids","volume":"6","author":"Cazzulo","year":"1992","journal-title":"FASEB J."},{"key":"10.1016\/j.bmc.2019.01.033_b0340","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.bbamcr.2006.08.019","article-title":"Metabolic functions of glycosomes in trypanosomatids","volume":"1763","author":"Michels","year":"2006","journal-title":"Biochim Biophys Acta - Mol Cell Res."},{"key":"10.1016\/j.bmc.2019.01.033_b0345","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1006\/scdb.2001.0282","article-title":"Reactive oxygen species and mitochondrial diseases","volume":"12","author":"Kirkinezos","year":"2001","journal-title":"Semin Cell Dev Biol."},{"key":"10.1016\/j.bmc.2019.01.033_b0350","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2164\/jandrol.108.005629","article-title":"Procyanidin induces apoptosis and necrosis of prostate cancer cell line PC-3 in a mitochondrion-dependent manner","volume":"30","author":"Shang","year":"2009","journal-title":"J Androl."},{"key":"10.1016\/j.bmc.2019.01.033_b0355","doi-asserted-by":"crossref","first-page":"C195","DOI":"10.1152\/ajpcell.00641.2005","article-title":"A role for mitochondrial aquaporins in cellular life-and-death decisions?","volume":"291","author":"Lee","year":"2006","journal-title":"AJP Cell Physiol."},{"key":"10.1016\/j.bmc.2019.01.033_b0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exppara.2006.10.007","article-title":"Miltefosine induces apoptosis in arsenite-resistant Leishmania donovani promastigotes through mitochondrial dysfunction","volume":"116","author":"Verma","year":"2007","journal-title":"Exp Parasitol."},{"key":"10.1016\/j.bmc.2019.01.033_b0365","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1042\/bst0310607","article-title":"Targeting metabolic pathways in microbial pathogens: oxidative stress and anti-folate drug resistance in trypanosomatids","volume":"31","author":"Hunter","year":"2003","journal-title":"Biochem Soc Trans."},{"key":"10.1016\/j.bmc.2019.01.033_b0370","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.ijpara.2009.05.010","article-title":"Enzymes of the antioxidant network as novel determiners of Trypanosoma cruzi virulence","volume":"39","author":"Piacenza","year":"2009","journal-title":"Int J Parasitol."},{"key":"10.1016\/j.bmc.2019.01.033_b0375","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1128\/AAC.48.1.130-136.2004","article-title":"In vitro and In vivo activities of a triterpenoid saponin extract (PX-6518) from the plant Maesa balansae against visceral Leishmania species","volume":"48","author":"Maes","year":"2004","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.bmc.2019.01.033_b0380","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1021\/jm031150y","article-title":"In vitro and in vivo anti-leishmanial activity of triterpenoid saponins isolated from Maesa balansae and some chemical derivatives","volume":"48","author":"Germonprez","year":"2005","journal-title":"J Med Chem."},{"key":"10.1016\/j.bmc.2019.01.033_b0385","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/jac\/47.5.537","article-title":"Mechanism of action of anti-proliferative lysophospholipid analogues against the protozoan parasite Trypanosoma cruzi: potentiation of in vitro activity by the sterol biosynthesis inhibitor ketoconazole","volume":"47","author":"Lira","year":"2001","journal-title":"J Antimicrob Chemother."},{"key":"10.1016\/j.bmc.2019.01.033_b0390","doi-asserted-by":"crossref","first-page":"11025","DOI":"10.1074\/jbc.273.18.11025","article-title":"Induction of ceramide-mediated apoptosis by the anticancer phospholipid analog, hexadecylphosphocholine","volume":"273","author":"Wieder","year":"1998","journal-title":"J Biol Chem."},{"key":"10.1016\/j.bmc.2019.01.033_b0395","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1128\/AAC.01415-06","article-title":"Miltefosine (hexadecylphosphocholine) inhibits cytochrome c oxidase in Leishmania donovani promastigotes","volume":"51","author":"Luque-Ortega","year":"2007","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.bmc.2019.01.033_b0400","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1128\/AAC.48.3.852-859.2004","article-title":"Miltefosine induces apoptosis-like death in Leishmania donovani promastigotes","volume":"48","author":"Paris","year":"2004","journal-title":"Antimicrob Agents Chemother."}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089618320327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089618320327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:01:24Z","timestamp":1760835684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089618320327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":80,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0968089618320327"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2019.01.033","relation":{},"ISSN":["0968-0896"],"issn-type":[{"type":"print","value":"0968-0896"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and biological evaluation of new long-chain squaramides as anti-chagasic agents in the BALB\/c mouse model","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2019.01.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}